Solbi Kim

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Engineered Salmonella delivering the NMDAR antagonist conantokin G synergizes with PD-L1 blockade to enhance colorectal cancer regression.

Engineered Salmonella delivering the NMDAR antagonist conantokin G synergizes with PD-L1 blockade to enhance colorectal cancer regression.

Journal: Experimental hematology & oncology
Published: January 21, 2026

Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosis.

Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosis.

Journal: Signal transduction and targeted therapy
Published: May 12, 2025

Attenuated Salmonella secreting interleukin-21 activates T-cells and induces anti-tumor effects.

Attenuated Salmonella secreting interleukin-21 activates T-cells and induces anti-tumor effects.

Journal: Acta pharmaceutica Sinica. B
Published: April 30, 2025

Tumour-specific delivery of ω-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy.

Tumour-specific delivery of ω-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy.

Journal: Journal of advanced research
Published: March 23, 2025

Engineering Bacterial Secretion Systems for Enhanced Tumor Imaging and Surgical Guidance.

Engineering Bacterial Secretion Systems for Enhanced Tumor Imaging and Surgical Guidance.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 05, 2025

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer.

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer.

Journal: Experimental hematology & oncology
Published: March 30, 2024

Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF.

Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF.

Journal: Acta pharmaceutica Sinica. B
Published: March 01, 2024

Hederacolchiside A1 Suppresses Autophagy by Inhibiting Cathepsin C and Reduces the Growth of Colon Cancer.

Hederacolchiside A1 Suppresses Autophagy by Inhibiting Cathepsin C and Reduces the Growth of Colon Cancer.

Journal: Cancers
Published: January 30, 2023

Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression in vitro.

Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression in vitro.

Journal: Oncology reports
Published: August 18, 2021

MITF Promotes Cell Growth, Migration and Invasion in Clear Cell Renal Cell Carcinoma by Activating the RhoA/YAP Signal Pathway.

MITF Promotes Cell Growth, Migration and Invasion in Clear Cell Renal Cell Carcinoma by Activating the RhoA/YAP Signal Pathway.

Journal: Cancers
Published: May 04, 2021

Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C.

Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C.

Journal: American journal of cancer research
Published: September 02, 2020

Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.

Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.

Journal: American journal of cancer research
Published: July 19, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026